IP79: Prostate Cancer: Localized: Surgical Therapy IV
Monday, May 18, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
145AB
Poster and Podium Sessions
Oncology: Prostate
Monday, May 18
IP79-01: PI-RADS–Stratified MRI PSA Density and Adverse Pathology after Radical Prostatectomy in the MRI Era
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-02: Patient Regret Following Focal Therapy vs Radical Prostatectomy for Prostate Cancer
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-03: Predicting Post-Prostatectomy Quality of Life: Machine Learning Models for Enhanced Patient-Centered Decision-Making
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-04: The Impact of Different Robotic Platforms on Functional and Oncological outcomes in patients treated with Retzius-sparing Robotic Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Alberto Quistini
IP79-05: Association between perineural invasion and increased risk of castration-resistant prostate cancer
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-06: Comparative Perioperative Outcomes of Extended Versus Limited Pelvic Lymph Node Dissection in Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer: A Phase III Randomized Trial
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-07: Enhanced Optical Zoom and Camera Efficiency in da Vinci Xi versus da Vinci 5 for Radical Prostatectomy: Impact on Surgical Workflow and Efficiency
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-08: THE MIAMI CANCER INSTITUTE TECHNIQUE: PUBOPROSTATIC LIGAMENT PRESERVATION WITH SELECTIVE DORSAL VENOUS COMPLEX LIGATION AND CYSTOURETHROPEXY
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-09: Dehydrated Human Amniotic Membrane for Early Return of Erectile Function After Robotic Radical Prostatectomy: A 10-Year Journey and Lessons Learned
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-10: Managing Robotic Radical Prostatectomy in Men with Penile Prosthesis: Surgical Technique and Outcomes
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-11: Comparative Trifecta Outcomes Following Radical Prostatectomy versus Focal Therapy for Localized Prostate Cancer: Functional and Oncologic Trade-offs in a Contemporary Cohort
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-12: Improved Sexual Function in Older Men Undergoing Posterior Approach to Endopelvic Neurovascular Total Sparing (PATENTS) Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-13: Comparison of Anastomotic Strictures by Retzius-Sparing vs. Anterior Approach Robotic-Assisted Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-14: Recurrence Patterns After Deferred Treatment in Biochemically Recurrent Prostate Cancer Following a Negative PSMA PET/CT
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Maya Ataya · Indiana University
IP79-15: Are Prebiopsy PI-RADS 5 Lesions Associated With Pathologic Upgrade after Robot-Assisted Radical Prostatectomy in Gleason Grade Group 2 Prostate Cancer?
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-16: Beyond continence control: a systematic review and meta-analysis of oncological outcomes in prostate cancer patients undergoing Retzius-sparing robot-assisted radical prostatectomy versus conventional robot-assisted radical prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-17: Opioid-free single-port robot-assisted radical prostatectomy under subarachnoid anesthesia: feasibility from the initial experience
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Michele Marchioni
IP79-18: Impact of Gleason grading on survival outcomes in patients with low loco-regional lymphogenic metastatic burden at radical prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-19: Development of Histologic Criteria for Objective Evaluation of The Quality of Nerve Sparing during Robot-Assisted Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Ahmed Aly · Roswell Park Comprehensive Cancer Center
IP79-20: Robot-assisted prostatectomy associated with 3D reconstruction for trifecta outcomes
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-21: Does obesity lead to higher positive surgical margins in patients undergoing robotic-assisted radical prostatectomy for non-metastatic prostate cancer? A propensity score matched analysis
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-22: Real Time Digital Pathology with 3D Augmented Reality guidance during RARP
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Enrico Checcucci
IP79-23: Comparative Outcomes of Salvage Robotic Radical Prostatectomy After Radiation Therapy Versus Focal Therapy: A Systematic Review and Meta-Analysis
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-24: Predicting Pathological Upstaging in Prostate Cancer: An Artificial Neural Network Integrating PSMA PET, PSA, and MRI in a South Asian Cohort
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-25: Extraperitoneal Robot-Assisted Radical Prostatectomy with the Hugo™ RAS System: 100 consecutive cases, 1-year follow-up and surgical learning curve evaluation
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-26: Impact of learning curve on perioperative and pathologic outcomes of single port robotic radical prostatectomy: results from a high-volume center
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Gabriele Tuderti · "Regina Elena" National Cancer Institute, Dept. of
IP79-27: Artificial intelligence–driven objective assessment of neurovascular bundle preservation predicts urinary continence recovery after robot-assisted radical prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-28: Development of a Preoperative Nomogram to Predict PSA Persistence After Robot-Assisted Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-29: Single Port Robotic Radical Prostatectomy in Septuagenarian Patients
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
IP79-30: Total en-bloc urethra preservation at robot-assisted prostatectomy (ToP-RAP): a prospective IDEAL stage I–IIa study
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB